Introduction: What they say: A study from the Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts, USA Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA; MIT…
read moreWhat we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for the lost pancreatic β-cells in Diabetic patients: Valproic acid promotes an insulin-sensitized state via up-regulation of its target gene…
read moreWhat we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-derived therapy for Allergic rhinitis: Shikonin, found in Zicao/Lithospermum erythrorhizon, inhibits GM-CSF, Interleukin 13 receptor(IL-13)-Rα1, and eotaxin…
read moreWhat we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for pulmonary fibrosis: Ethinylestradiol decreases miR-34 expression, increases Sirtuin-1 expression, suppresses tumor suppressor p53 acetylation, prevents apoptosis in…
read moreIntroduction: What they say A study from the Global Research Laboratory, Seoul National University, Korea shows that “Overexpression of Atg5 in mice activates autophagy and extends lifespan.” This study was published in the online…
read moreWhat we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-derived therapy for Regenerating the lost pancreatic β-cells in Diabetic patients: Glycyrrhizin, isolated from Licorice (Glycyrrhiza uralensis Fischer), promotes an insulin-sensitized state…
read more